3.2.2.6	1,N6-etheno NAD+	-	166360	
3.2.2.6	1-[2-azido-2-deoxy-5-O-phosphono-D-threo-pentofuranosyl]-3-carbamoylpyridinium	inhibition of the NADase activity	199552	
3.2.2.6	1-[5-O-[(benzyloxy)(hydroxy)phosphoryl]-2-deoxy-2-fluoro-L-erythro-pentofuranosyl]-3-carbamoylpyridinium	inhibition of the NADase activity	199553	
3.2.2.6	1-[5-O-[butoxy(hydroxy)phosphoryl]-2-deoxy-2-fluoro-D-threo-pentofuranosyl]-3-carbamoylpyridinium	inhibition of the NADase activity	199557	
3.2.2.6	2'-deoxy-2'-beta-D-fluoroarabinofuranoside NAD+	-	201226	
3.2.2.6	2'-deoxy-2'-beta-D-fluororibofuranoside NAD+	non-covalent complex of the inhibitor formed with enzyme mutant E218Q, PDB ID: 3ghh, and with wild-type enzyme, PDB ID: 3kou	201225	
3.2.2.6	3-aminopyridine	-	13040	
3.2.2.6	3-carbamoyl-1-[2-chloro-2-deoxy-5-O-phosphono-D-threo-pentofuranosyl]pyridinium	inhibition of the NADase activity	199551	
3.2.2.6	3-carbamoyl-1-[2-deoxy-2-fluoro-5-O-phosphono-D-threo-pentofuranosyl]pyridinium	inhibition of the NADase activity	199546	
3.2.2.6	3-carbamoyl-1-[2-deoxy-2-fluoro-5-O-phosphono-L-threo-pentofuranosyl]pyridinium	inhibition of the NADase activity	199549	
3.2.2.6	3-carbamoyl-1-[2-deoxy-2-fluoro-5-O-thiophosphono-L-erythro-pentofuranosyl]pyridinium	inhibition of the NADase activity	199554	
3.2.2.6	3-carbamoyl-1-[2-deoxy-2-fluoro-5-O-[(hexyloxy)(hydroxy)phosphoryl]-D-threo-pentofuranosyl]pyridinium	inhibition of the NADase activity	199555	
3.2.2.6	3-carbamoyl-1-[2-deoxy-2-fluoro-5-O-[hydroxy(2-phenylethoxy)phosphoryl]-L-erythro-pentofuranosyl]pyridinium	inhibition of the NADase activity	199556	
3.2.2.6	3-carbamoyl-1-[2-deoxy-2-fluoro-D-threo-pentofuranosyl]pyridinium	inhibition of the NADase activity	199545	
3.2.2.6	3-carbamoyl-1-[2-deoxy-5-O-(diethoxyphosphoryl)-2-fluoro-D-threo-pentofuranosyl]pyridinium	inhibition of the NADase activity	199548	
3.2.2.6	3-carbamoyl-1-[2-deoxy-5-O-[(ethenyloxy)(propoxy)phosphoryl]-2-fluoro-D-threo-pentofuranosyl]pyridinium	inhibition of the NADase activity	199547	
3.2.2.6	3-carbamoyl-1-[3-deoxy-3-fluoro-5-O-phosphono-L-threo-pentofuranosyl]pyridinium	inhibition of the NADase activity	199550	
3.2.2.6	5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chromenium	-	85303	
3.2.2.6	ADP-ribose	-	402	
3.2.2.6	Ag+	50% inhibition of NADase and 300% activation of adenosine diphosphate cyclase; at 2 mM 50% inhibition of NADase activity and 300% activation of cADPR activity	75	
3.2.2.6	arabinosyl 2'-fluoro-2'-deoxy-NAD	suicide substrate that inhibits CD38 ectoenzyme activity	165979	
3.2.2.6	arabinosyl-2'-fluoro-2'-deoxynicotinamide mononucleotide	inhibition of the NADase activity	201227	
3.2.2.6	Cr3+	inhibition of NADase and adenosine diphosphate cyclase	895	
3.2.2.6	cyanidin	-	1072	
3.2.2.6	delphinidin	-	1824	
3.2.2.6	fisetinidin	-	28423	
3.2.2.6	HClO4	5%, 2°C, 10 min, 60% loss of the original activity	32245	
3.2.2.6	Hg2+	10 mM HgCl2, 70% inhibition	33	
3.2.2.6	Hg2+	complete inhibition at 2 mM; inhibition of NADase and adenosine diphosphate cyclase	33	
3.2.2.6	Isonicotinic acid hydrazide	-	2409	
3.2.2.6	kuromanin	-	19203	
3.2.2.6	luteolin	-	436	
3.2.2.6	luteolinidin	-	28422	
3.2.2.6	malvidin	-	3646	
3.2.2.6	additional information	high resistance to inhibition by nicotinamide	2	
3.2.2.6	additional information	NADase inhibitor from Pseudomonas putida KB1	2	
3.2.2.6	additional information	not inhibited by rac-taxifolin, rac-catechin, piceatannol, and trans-resveratrol	2	
3.2.2.6	myricetin	-	484	
3.2.2.6	nicotinamide	inhibition involves enzyme residue Trp181	267	
3.2.2.6	Pb2+	complete inhibition at 2 mM; inhibition of NADase and adenosine diphosphate cyclase	139	
3.2.2.6	pelargonidin	-	2754	
3.2.2.6	peonidin	-	4381	
3.2.2.6	petunidin	-	5391	
3.2.2.6	Pyridine	non-competitive inhibition of mutant E218A by pyridine	2033	
3.2.2.6	quercetagetin	-	4128	
3.2.2.6	quercetagetinidin	-	28421	
3.2.2.6	quercetin	-	137	
3.2.2.6	robinetin	-	19469	
3.2.2.6	SDS	-	124	
3.2.2.6	Sn2+	complete inhibition at 2 mM; inhibition of NADase and adenosine diphosphate cyclase	413	
3.2.2.6	Zn2+	inhibition of NADase and adenosine diphosphate cyclase	14